Quest for Medical Therapy for Alzheimer’s Disease Continues

Clinical trials for disease-modifying therapy for Alzheimer’s disease are underway.

Novel Monoclonal Antibody Could Transform High-Risk Neuroblastoma Treatment

Researchers at St. Jude Children’s Research Hospital found that adding a novel anti-disialoganglioside GD2 (anti-GD2) monoclonal antibody to the standard therapy for children newly diagnosed with high-risk neuroblastoma significantly enhanced response to treatment and improved survival. Their findings could be transformative if additional studies can produce similar results.

The Importance of Screening for Genitourinary Syndrome of Menopause

New recommendations suggest every woman should be screened, whether or not they bring it up during an exam.

Health Systems’ Child Care Carrot

Facing a labor shortage, health organizations seek to attract and retain workers by offering solutions to one of their biggest financial pain points: child care.